AJP - Endocrinology and Metabolism, Vol 245, Issue 1 87-E93, Copyright © 1983 by American Physiological Society

ARTICLES

Studies of origins of abnormal sympathetic function in obese Zucker rats

B. E. Levin, J. Triscari and A. C. Sullivan

To explain previously described abnormalities of sympathetic function in the genetically obese Zucker rat, the kinetics of norepinephrine (NE) metabolism were examined. Lower stress-induced levels of plasma NE in the obese rat were shown to be due to decreased release of NE because uptake of [3H]NE tracer from plasma was 45% slower in the obese compared with the lean rat. NE levels were 15, 20, and 34% lower in heart, pancreas, and interscapular brown adipose tissue (IBAT), and NE turnover rates (determined by two independent methods) were 39-48 and 43-69% lower in the pancreas and IBAT of obese compared with lean rats. In vivo synthesis of [3H]NE from [3H]dopamine by the enzyme dopamine beta-hydroxylase was 60% lower in IBAT but was equal in hearts of obese compared with lean rats. These results suggest an organ-specific decrease of NE synthesis in the obese Zucker rat, possibly due to decreased dopamine beta-hydroxylase activity in IBAT.

This article has been cited by other articles:

				P. Ruggeri, A. Brunori, C. E. Cogo, D. Storace, F. Di Nardo, and R. Burattini Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R376 - R382. [Abstract] [Full Text] [PDF]

				M. Duclos, E. Timofeeva, C. Michel, and D. Richard Corticosterone-dependent metabolic and neuroendocrine abnormalities in obese Zucker rats in relation to feeding Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E254 - E266. [Abstract] [Full Text] [PDF]

				J. M. Overton, T. D. Williams, J. B. Chambers, and M. E. Rashotte Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1007 - R1015. [Abstract] [Full Text] [PDF]

				J. C. Clapham and N. C. Turner Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1503 - 1508. [Abstract] [Full Text]

				M. Alonso-Galicia, M. W. Brands, D. H. Zappe, and J. E. Hall Hypertension in Obese Zucker Rats: Role of Angiotensin II and Adrenergic Activity Hypertension, December 1, 1996; 28(6): 1047 - 1054. [Abstract] [Full Text]

				G. Grassi, G. Seravalle, B. M. Cattaneo, G. B. Bolla, A. Lanfranchi, M. Colombo, C. Giannattasio, A. Brunani, F. Cavagnini, and G. Mancia Sympathetic Activation in Obese Normotensive Subjects Hypertension, April 1, 1995; 25(4): 560 - 563. [Abstract] [Full Text]

				D. A. Morgan, E. A. Anderson, and A. L. Mark Renal Sympathetic Nerve Activity Is Increased in Obese Zucker Rats Hypertension, April 1, 1995; 25(4): 834 - 838. [Abstract] [Full Text]